Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples